Drug Profile


Alternative Names: Beta-sitosterol; Harzol

Latest Information Update: 27 Jan 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Hoyer
  • Class Phytosterols; Phytotherapies
  • Mechanism of Action Cholesterol inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Benign prostatic hyperplasia
  • Discontinued Hyperlipidaemia

Most Recent Events

  • 31 Dec 2002 Development discontinued for Hyperlipidaemia before 2003
  • 08 Aug 2000 A study has been added to the Men's Health therapeutic trials section
  • 19 Jul 1999 A meta-analysis has been added to the Men's Health therapeutic trials and adverse events sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top